These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 14601154)

  • 1. If the price is right: vagueness and values clarification in contingent valuation.
    Shiell A; Gold L
    Health Econ; 2003 Nov; 12(11):909-19. PubMed ID: 14601154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of 'reference goods' in contingent valuation: should we help respondents to 'construct' their willingness to pay?
    Smith RD
    Health Econ; 2007 Dec; 16(12):1319-32. PubMed ID: 17328037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Values for preventing influenza-related morbidity and vaccine adverse events in children.
    Prosser LA; Bridges CB; Uyeki TM; Rêgo VH; Ray GT; Meltzer MI; Schwartz B; Thompson WW; Fukuda K; Lieu TA
    Health Qual Life Outcomes; 2005 Mar; 3():18. PubMed ID: 15780143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Willingness to pay methods in health care: a sceptical view.
    Cookson R
    Health Econ; 2003 Nov; 12(11):891-4. PubMed ID: 14601152
    [No Abstract]   [Full Text] [Related]  

  • 5. Do ordering effects matter in willingness-to-pay studies of health care?
    Stewart JM; O'Shea E; Donaldson C; Shackley P
    J Health Econ; 2002 Jul; 21(4):585-99. PubMed ID: 12146592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When do the "dollars" make sense? Toward a conceptual framework for contingent valuation studies in health care.
    O'Brien B; Gafni A
    Med Decis Making; 1996; 16(3):288-99. PubMed ID: 8818128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual responsibility and health-risk behaviour: a contingent valuation study from the ex ante societal perspective.
    van der Star SM; van den Berg B
    Health Policy; 2011 Aug; 101(3):300-11. PubMed ID: 21168930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between reliability and size of willingness-to-pay values: a qualitative insight.
    Smith RD
    Health Econ; 2007 Feb; 16(2):211-6. PubMed ID: 16929470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equity shortfalls & failure of the welfare state: community willingness to pay for health care at government facilities in Jehlum (Pakistan).
    Masud TI; Farooq N; Ghaffar A
    J Ayub Med Coll Abbottabad; 2003; 15(4):43-9. PubMed ID: 15067833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Willingness to pay for a reduction in mortality risk after a myocardial infarction: an application of the contingent valuation method to the case of eplerenone.
    Pinto-Prades JL; Farreras V; de Bobadilla JF
    Eur J Health Econ; 2008 Feb; 9(1):69-78. PubMed ID: 17447095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subject variation more than values clarification explains the reliability of willingness to pay estimates.
    Shiell A; McIntosh K
    Health Econ; 2008 Feb; 17(2):287-92. PubMed ID: 17619235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contingent valuation study of Heiðmörk, Iceland - Willingness to pay for its preservation.
    Cook D; Eiríksdóttir K; Davíðsdóttir B; Kristófersson DM
    J Environ Manage; 2018 Mar; 209():126-138. PubMed ID: 29288935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of range bias in contingent valuation payment scales.
    Whynes DK; Wolstenholme JL; Frew E
    Health Econ; 2004 Feb; 13(2):183-90. PubMed ID: 14737755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. It's not just what you do, it's the way that you do it: the effect of different payment card formats and survey administration on willingness to pay for health gain.
    Smith RD
    Health Econ; 2006 Mar; 15(3):281-93. PubMed ID: 16200558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Willingness to pay for publicly financed health care services in Central and Eastern Europe: evidence from six countries based on a contingent valuation method.
    Tambor M; Pavlova M; Rechel B; Golinowska S; Sowada C; Groot W
    Soc Sci Med; 2014 Sep; 116():193-201. PubMed ID: 25016327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Framing the willingness-to-pay question: impact on response patterns and mean willingness to pay.
    Gyrd-Hansen D; Jensen ML; Kjaer T
    Health Econ; 2014 May; 23(5):550-63. PubMed ID: 23696155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Willingness-to-pay (WTP): the new-old kid on the economic evaluation block.
    Gafni A
    Can J Nurs Res; 2001 Jun; 33(1):59-64. PubMed ID: 11928155
    [No Abstract]   [Full Text] [Related]  

  • 18. Willingness-to-pay for reductions in care need: estimating the value of informal care in Alzheimer's disease.
    Gustavsson A; Jönsson L; McShane R; Boada M; Wimo A; Zbrozek AS
    Int J Geriatr Psychiatry; 2010 Jun; 25(6):622-32. PubMed ID: 19750558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients' willingness to pay for autologous blood donation.
    Lee SJ; Neumann PJ; Churchill WH; Cannon ME; Weinstein MC; Johannesson M
    Health Policy; 1997 Apr; 40(1):1-12. PubMed ID: 10165898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contingency of contingent valuation. How much are people willing to pay against Alzheimer's disease?
    Nocera S; Bonato D; Telser H
    Int J Health Care Finance Econ; 2002 Sep; 2(3):219-40. PubMed ID: 14625942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.